MARLENE DEBEL - 22 Feb 2022 Form 4 Insider Report for METLIFE INC (MET)

Role
EVP & Chief Risk Officer
Signature
/s/ Stephen W. Gauster, Authorized Signer
Issuer symbol
MET
Transactions as of
22 Feb 2022
Net transactions value
-$282,598
Form type
4
Filing time
24 Feb 2022, 18:59:58 UTC
Previous filing
03 Dec 2021
Next filing
25 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award +5,330 +12% 48,442 22 Feb 2022 Direct F1
transaction MET Common Stock Award +11,313 +23% 59,755 22 Feb 2022 Direct F2
transaction MET Common Stock Tax liability $282,598 -4,098 -6.9% $68.96 55,657 22 Feb 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Award $0 +15,986 $0.000000 15,986 22 Feb 2022 Common Stock 15,986 $68.96 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F2 Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F3 Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
F4 The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.